Integral Diagnostics Sustainability Profile
Integral Diagnostics, a leading provider of diagnostic imaging services, is headquartered in Australia and operates extensively across major regions including Queensland, Victoria, and Western Australia. Founded in 2006, the company has established itself as a key player in the healthcare sector, focusing on high-quality radiology services. Specialising in a range of imaging modalities such as MRI, CT, and ultrasound, Integral Diagnostics is recognised for its commitment to advanced technology and patient care. The company’s unique approach combines state-of-the-art equipment with a team of highly skilled professionals, ensuring accurate and timely diagnoses. With a strong market position, Integral Diagnostics has achieved significant milestones, including numerous accreditations and partnerships that enhance its service offerings. As a trusted name in the industry, Integral Diagnostics continues to set benchmarks for excellence in diagnostic imaging.
DitchCarbon Score
How does Integral Diagnostics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Integral Diagnostics's score of 21 is lower than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Integral Diagnostics's reported carbon emissions
In 2025, Integral Diagnostics reported total carbon emissions of approximately 32,746,000 kg CO2e, comprising 645,000 kg CO2e from Scope 1, 12,993,000 kg CO2e from Scope 2 (market-based), and 18,492,000 kg CO2e from Scope 3 emissions. For the previous year, 2024, the company recorded total emissions of about 32,174,000 kg CO2e, with Scope 1 emissions at 470,000 kg CO2e, Scope 2 emissions at 8,126,000 kg CO2e (market-based), and Scope 3 emissions at 17,720,000 kg CO2e. Integral Diagnostics has not set specific reduction targets or initiatives as part of their climate commitments, and there are no emissions data cascaded from a parent company. The company has disclosed emissions data for Scopes 1, 2, and 3, demonstrating a comprehensive approach to tracking their carbon footprint. The reported emissions figures indicate a significant reliance on Scope 3 emissions, which often represent the largest share of total emissions for organisations in the healthcare sector. Integral Diagnostics continues to monitor and report its emissions, reflecting an ongoing commitment to transparency in its environmental impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Scope 1 | 432,700 | 000,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 6,716,500 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 |
| Scope 3 | - | - | - | 00,000,000 | 00,000,000 |
How Carbon Intensive is Integral Diagnostics's Industry?
How Carbon Intensive is Integral Diagnostics's Location?
Integral Diagnostics's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Integral Diagnostics has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
